We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$31.3M
Cap. Flow
+$2.28M
Cap. Flow %
1.84%
Top 10 Hldgs %
30.99%
Holding
124
New
34
Increased
26
Reduced
39
Closed
14

Top Buys

Rank Stock Value
1
UBX
Unity Biotechnology
UBX
+$4.51M
2
SPOT icon
Spotify
SPOT
+$1.47M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$1.31M
4
CNC icon
Centene
CNC
+$1.21M
5
APTX
Aptinyx Inc. Common Stock
APTX
+$1.17M

Top Sells

Rank Stock Value
1
ALNA
Allena Pharmaceuticals
ALNA
+$4M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.52M
3
MSFT icon
Microsoft
MSFT
+$2.51M
4
BAX icon
Baxter International
BAX
+$1.81M
5
BOX icon
Box
BOX
+$1.26M

Sector Composition

Rank Sector Weight
1 Healthcare 50.9%
2 Miscellaneous 19.79%
3 Technology 12.71%
4 Communication Services 9.85%
5 Consumer Discretionary 3.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$489B
$9.05M 7.31%
+52,700
New +$8.84M
IWM icon
2
PUT
iShares Russell 2000 ETF
IWM
$80.8B
$4.55M 3.68%
+27,800
New +$4.45M
UBX
3
DELISTED
Unity Biotechnology
UBX
$4.08M 3.29%
+30,876
New +$4.51M
ALNA
4
DELISTED
Allena Pharmaceuticals
ALNA
$3.88M 3.14%
298,005
-277,402
-48% -$4M
ELV icon
5
Elevance Health
ELV
$85.5B
$3.41M 2.76%
14,344
+591
+4% +$137K
JAZZ icon
6
Jazz Pharmaceuticals
JAZZ
$15.9B
$2.99M 2.41%
17,334
+1,796
+12% +$294K
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$4.24T
$2.68M 2.17%
47,480
+20,560
+76% +$1.12M
CRM icon
8
Salesforce
CRM
$211B
$2.61M 2.11%
19,153
+4,770
+33% +$609K
PTLA
9
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.6M 2.1%
68,808
-3,476
-5% -$133K
VTRS icon
10
Viatris
VTRS
$18.8B
$2.52M 2.04%
69,879
-4,971
-7% -$195K
BIDU icon
11
Baidu
BIDU
$32.9B
$2.37M 1.91%
9,738
+3,769
+63% +$938K
AERI
12
DELISTED
Aerie Pharmaceuticals
AERI
$2.34M 1.89%
34,580
-1,891
-5% -$106K
EEM icon
13
PUT
iShares MSCI Emerging Markets ETF
EEM
$31.2B
$2.19M 1.77%
+50,500
New +$2.34M
THC icon
14
Tenet Healthcare
THC
$21.5B
$2.1M 1.69%
62,424
+12,610
+25% +$392K
BABA icon
15
Alibaba
BABA
$296B
$1.95M 1.58%
10,529
+3,307
+46% +$630K
ZBH icon
16
Zimmer Biomet
ZBH
$19.2B
$1.92M 1.55%
17,725
-1,433
-7% -$156K
HUM icon
17
Humana
HUM
$46.3B
$1.84M 1.49%
6,185
-553
-8% -$162K
GDDY icon
18
GoDaddy
GDDY
$12.4B
$1.81M 1.46%
25,653
-7,985
-24% -$543K
ABT icon
19
Abbott
ABT
$195B
$1.65M 1.33%
27,034
-9,881
-27% -$599K
INTU icon
20
Intuit
INTU
$97.9B
$1.61M 1.3%
7,889
+1,612
+26% +$309K
DATA
21
DELISTED
Tableau Software, Inc.
DATA
$1.54M 1.25%
15,800
-5,086
-24% -$466K
SPOT icon
22
Spotify
SPOT
$113B
$1.54M 1.25%
+9,164
New +$1.47M
UNH icon
23
UnitedHealth
UNH
$353B
$1.49M 1.2%
6,055
-4,612
-43% -$1.11M
EW icon
24
Edwards Lifesciences
EW
$52B
$1.48M 1.2%
30,552
-4,518
-13% -$211K
PBYI icon
25
Puma Biotechnology
PBYI
$468M
$1.4M 1.13%
23,694
-3,460
-13% -$201K
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Partner Investment Management held 124 positions worth $124M, up 34% from $92.6M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Partner Investment Management's Q2 2018 filing shows 34 new, 26 increased, 39 reduced and 14 closed positions. Its largest new stake was Unity Biotechnology: 30,876 shares worth $4.08M. The largest sale was Allena Pharmaceuticals, an estimated $4M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 64% a quarter earlier, followed by Miscellaneous and Technology.

  • Partner Investment Management's largest Q2 2018 buy was Unity Biotechnology: 30,876 shares worth $4.08M.
  • Partner Investment Management added most to Alphabet (Google) Class A in Q2 2018, an estimated $1.12M increase.
  • Partner Investment Management's biggest Q2 2018 reduction was Allena Pharmaceuticals, cutting an estimated $4M.
  • Partner Investment Management fully exited Bristol-Myers Squibb in Q2 2018, selling an estimated $3.52M.
  • Partner Investment Management's ten largest holdings make up 31% of its $124M portfolio in Q2 2018.
  • Partner Investment Management opened 34 new positions and closed 14 in Q2 2018.
  • Partner Investment Management's portfolio value rose 34% quarter-over-quarter to $124M.

Based on Partner Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.